Aclidinium bromide is a long-acting, selective muscarinic antagonist used as a bronchodilator for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). By inhibiting muscarinic… Read more











Aclidinium bromide is a long-acting, selective muscarinic antagonist used as a bronchodilator for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). By inhibiting muscarinic acetylcholine receptors, specifically the M3 subtype in airway smooth muscle, this anticholinergic agent facilitates bronchodilation and improves airflow in patients. Our catalogue provides essential analytical tools for this drug, featuring a comprehensive selection of reference standards, including the active pharmaceutical ingredient, identified impurities, potential degradation products, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for impurity profiling, method validation, and rigorous quality control testing to ensure the safety, purity, and efficacy of drug products. Whether conducting routine batch release, stability studies, or method development, these well-characterized standards enable accurate identification and quantification, supporting compliance with regulatory guidelines throughout the pharmaceutical lifecycle.